Quality Assessment | |||||||
---|---|---|---|---|---|---|---|
Author | OAR studied | OAR defined | Toxicity definition | Pts with toxicity | Significant findings | Statistical considerations met (1–7) | Endpoint considerations met (1–3) |
Chopra [11] | Large bowel | 2 cm above target, individual loops of large bowel (unclear how differentiated from small bowel) | CTCAE v3.0 Gr ≥ 3 | 9/71 (12.6%) | V15 associated with ≥gr 3 toxicity. Constraints: V15 < 250 cc, V30 < 100 cc, V40 < 90 cc to reduce toxicity from 26.7 to 5.4% | 1, 4, 6 (n/a 2,3) | 2 |
Isohashi [10] | Large bowel | Single loop continuing from end of sigmoid to ascending colon | RTOG/EORTC, Gr ≥ 2 | 16/97 (16.5%) | No constraint found for large bowel | 1,7 (n/a 2–6) | 2 |
Fonteyne [17] | Sigmoid colon | Where rectum sweeps anteriorly to one slice above aortic bifurcation | RTOG and “RILIT” Gr 1 and 2 | Gr 1112/241 (46%), Gr 2 32/241 (13%). | V40 associated with gr1 diarrhoea & blood loss. Constraints: V40 < 10%, V30 < 16% to avoid gr1–2 diarrhoea | 1, 7 (n/a 3) | 1,2 |
Mouttet-Audouard [6] | Sigmoid colon | Anterior curvature of sigmoid colon to anterior abdominal wall | CTCAE v4.0 Gr1–3 diarrhoea and “whole digestive toxicity” | 8/37 (21.6%) diarrhoea; 17/37 (46%) (whole tox) | ‘Whole late digestive toxicity’ associated with V30–40. No specific constraints. | 1,7 (n/a 2–6) | 1,2 |
Lind [12] | Sigmoid colon | From where rectum deviates from its mid- position to where it turns cranially in left abdomen connecting to colon descendens | Defecation into clothing without warning > 1 in last 6 months | 63/519 (12.1%) | Mean dose>50Gy to small bowel or sigmoid or anal sphincter region associated with symptom (findings for individual organs not clarified) | 1, 7 (n/a 2–6) | 1,2,3 |
al-Abany [18] | Anal sphincter region | Caudal 3 cm of the rectum from anal verge (including filling) | Own questionnaire; Faecal leakage >2X/week | 9/65 (13.8%) faecal leakage | Increased risk with mean dose of 45-55Gy. Constraints: V35 < 60%, V40 < 40% associated with no risk of faecal leakage. | 1, 7 (n/a 2,3) | 1,2,3 |
Alsadius [19] | Anal sphincter region | Caudal part of large bowel, from end of rectal ampulla where bowel no longer had visible content or air. | Own questionnaire; Faecal leakage >once per month | 51/403 (12.7%) faecal leakage | Dmean<40Gy reduces risk from 17 to 4%. | 1,2,4,7 (n/a 3) | 1,2,3 |
Fokdal [14] | Anal canal | Outer contour of the structure extending from anal verge 2 cm cranially | LENT SOMA score | Urge: 27/71 (38%); Incontinence: 21/71 (30%) | Urgency related to Dmed> 33.8: increases toxicity 31 to 47% Incontinence related to Dmax> 53.8 increases 14 to 44% | 1,2,4,5,7 (n/a 3) | 1,2,3 |
Vordermark [23] | Anal canal | Anal verge to the section below visible rectal lumen, corresponding to the upper border of the levator ani muscle | “Solid soiling” (Severe incontinence) Own continence questionnaire | 6/44 (14%) | Severe incontinence - associated with Dmin (23.1Gy) - related to portals extending 2 mm below ischial tuberosities (compared with 5 mm above) | 1, 7 (n/a 2–3) | 1,2,3 |
Koper [25] | Anal canal | Caudal 3 cm of the intestine | RTOG gr1 + 2; Plus symptom questionnaire. | 141/248 (57%) | D90% (=54.9Gy) to associated with ≥ gr1 rectal toxicity | 1, 7 (n/a 2–6) | 2,3 |
Taussky [37] | Anal canal | Most distal 2-3 cm of rectum | 10 questions from UCLA-PCI, FACT-P & EORTC QLQ -PR25 | Unclear | no relation with anal canal DVH found | 7 (N/a: 2–3) | 3 |
Buettner [20] | Anal canal | Caudal 3 cm of rectum | Common grading scheme; subjective sphincter control at highest grade | 57/388 (14.7%) | DSH data: Toxicity correlated with dose to anal surface: lateral extent 53Gy > 56%. DVH data: Dmean 47Gy to anal sphincter volume correlated with sphincter toxicity. Constraints: Dmean<30Gy.NTCP modeling to LKB model TD50 = 120, m = 0.42. | 1,3,6,7 (n/a 2) | 1,2,3 |
Peeters [21] | Anal wall | Wall of caudal 3 cm of anorectum (method described) | RTOG/EORTC ≥ gr 2 and ≥ gr 3 Plus incontinence pad use>2x/wk. | ≥gr 2165/641 (25.7%) ≥ gr 3 27/641 4.2% | Dmean increase from 19Gy to 52Gy increased gr2 toxicity: 16 to 31%. V65 & Dmean most significant for incontinence. Dmean increase by 33Gy increased incontinence by 12% | 1,2,4,6,7 (n/a 3) | 1,2 |
Mavroidis [27] | Anal sphincter region | Musculaure layer around the rectal aperture, 3 cm caudal from anal verge | Own questionnaire | faecal leakage 19/65 (29%); blood/mucus 22/65 (34%) | Relative seriality NTCP model of anal sphincter for incontinence, blood/mucus. Parameters for incontinence: D50 = 70.2Gy, γ = 1.22, s = 0.35. Parameters for blood/mucus: D50 = 74.0Gy, γ = 0.75, s ≈ 0 | 1, 3, 5, 6, 7 (n/a 2) | 1,3 |
Peeters [28] | Anal canal wall | Wall of caudal 3 cm of anorectum (method described) | Incontinence requiring pad use>2x/wk.; | 32/368 (7%) | NTCP LKB model of incontinence with anal wall dose. Parameters found were n = 7.48; TD50 = 105; m = 0.46 | 1,3,4,5,6,7 (n/a: 2) | 1,3 |
Smeenk [26] | Anal sphincter muscles | Individual muscles defined (Internal anal sphincter (IAS), external anal sphincter (EAS), puborectalis & levator ani) | Frequency, Urgency, Incontinence | 21/48 (44%) | For complication <5% Dmean<30Gy to IAS; <10Gy to EAS, < 50Gy to puborectalis, <40Gy to levator ani | 1, 4,5 (n/a 2) | 1,2,3 |
Smeenk [22] | Anal wall | Continuation of rectal wall from anal verge to slice below lowest slice with a rectal balloon | Frequency, urgency, incontinence | 39% frequency, 31% urgency, 31% incontinence | For urgency: Anal wall Dmean<38Gy risk < 15%, >38Gy risk is 62% | 1,4,7 (n/a 2,3,5,6) | 1,3 |
Lind [12] | Anal sphincter region | Inner muscle layer of the sphincter up to anal verge | Defecation into clothing without warning > 1 in last 6 months | 63/519 (12.1%) | Mean dose>50Gy to small bowel or sigmoid or anal sphincter region associated with this symptom (findings for individual organs not clarified) | 1, 7 (n/a 2,3) | 1,2,3 |
Yeoh [24] | Anal wall | From anorectal junction (not clearly defined) | LENT-SOMA total score | 72% | Anal wall V40 > 65% associated with chronic toxicity. | 1,5 (n/a 2,3) | 2,3 |
Thor [29] | Anal sphincter | Anal canal, inner and outer sphincter (not clearly defined) | Questionnaire of 19 questions in 4 domains: pain urgency, mucus & incontinence. | Specific to each of 19 question | 5 LKB models proposed for anal sphincter doses. Low anal sphincter dose associated with faecal leakage and pain. High anal sphincter dose associated with leakage. | 1,3,6 (n/a 2) | 1,2,3 |
Ebert [35] | Anal Canal | Caudal 3 cm of anorectum | LENT-SOMA – 8 symptoms | Specific to each symptom | Bleeding associated with >40Gy, proctitis with 36-63Gy, frequency with 8-85Gy, urgency and tenesmus with 5-34Gy to anal canal. | 1,5,7 (n/a 2) | 1,2,3 |